Risk mitigation during concizumab prophylaxis in phase 3 clinical trials in patients with hemophilia a/b with and without inhibitors: management of breakthrough bleeds and dose optimization
AMERICAN JOURNAL OF HEMATOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要